44
Participants
Start Date
February 27, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
DAY101
28 day cycle, oral, once per week
Children's Hospital of Philadelphia, Philadelphia
Children's National Hospital, Washington D.C.
Johns Hopkins University, Baltimore
University of Florida, Gainesville
Children's Minnesota, Minneapolis
Washington University in St. Louis, St Louis
University of Utah, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
University of California, San Diego, San Diego
University of California, San Francisco, San Francisco
Oregon Health & Science University, Portland
Seattle Children's Hospital, Seattle
Massacusetts General Hospital, Boston
Boston Children's Hospital, Boston
Dana-Farber Cancer Institite, Boston
Collaborators (1)
PLGA Fund at Pediatric Brain Tumor Foundation
UNKNOWN
National Cancer Institute (NCI)
NIH
Pacific Pediatric Neuro-Oncology Consortium
OTHER
Team Jack Foundation
UNKNOWN
Day One Biopharmaceuticals, Inc.
INDUSTRY
Karen D. Wright, MD
OTHER